Asthma Related Healthcare Resource Use amongst asthmatic children with and without concommitant allergic rhinitis

Michael David Thomas, Vasilisa Sazonov Kocevar, Q. Zhang, D. D. Yin, David Brendan Price

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

Objective. To determine the incremental effect of allergic rhinitis on health care resource use in children with asthma.

Design. Population-based historical cohort study.

Setting. Data in a general practice database in the United Kingdom during 1998 to 2001.

Patients. Children 6 to 15 years old with asthma and with greater than or equal to1 asthma-related visits to a general practitioner (GP) during a 12-month follow-up period.

Main Outcome Measures. Asthma-related hospitalizations, GP visits, and prescription drug costs during the 12-month follow-up period for patients with and without comorbid allergic rhinitis.

Results. Of 9522 children with asthma, 1879 (19.7%) had allergic rhinitis recorded in the GP medical records. Compared with children with asthma alone, children with comorbid allergic rhinitis experienced more GP visits (4.4 vs 3.4) and more of them were hospitalized for asthma (1.4% vs 0.5%) during the 12-month follow-up period. In multivariable regression analyses, comorbid allergic rhinitis was an independent predictor of hospitalization for asthma (odds ratio: 2.34; 95% confidence interval [CI]: 1.41-3.91) and was associated with increases in the number of asthma-related GP visits (mean increase: 0.53; 95% CI: 0.52-0.54) and asthma drug costs (mean increase pound: 6.7; 95% CI: 6.5-7.0). The association between allergic rhinitis and higher costs of prescriptions for asthma drugs was independent of asthma severity, measured indirectly by the intensity of use of asthma drugs.

Conclusions. Children with comorbid allergic rhinitis incurred greater prescription drug costs and experienced more GP visits and hospitalizations for asthma than did children with asthma alone. A unified treatment strategy for asthma and allergic rhinitis, as recommended by the Allergic Rhinitis and Its Impact on Asthma initiative, might reduce the costs of treating these conditions.

Original languageEnglish
Pages (from-to)129-131
Number of pages2
JournalPediatrics
Volume115
DOIs
Publication statusPublished - 1 Jan 2005

Keywords

  • asthma
  • allergic rhinitis
  • children
  • medical resource use
  • BRONCHIAL RESPONSIVENESSbronchial responsiveness
  • United-States
  • cost
  • symptoms
  • rhinoconjunctivitis
  • inflammation
  • childhood
  • prevalence
  • increase

Cite this

Asthma Related Healthcare Resource Use amongst asthmatic children with and without concommitant allergic rhinitis. / Thomas, Michael David; Kocevar, Vasilisa Sazonov; Zhang, Q.; Yin, D. D.; Price, David Brendan.

In: Pediatrics, Vol. 115, 01.01.2005, p. 129-131.

Research output: Contribution to journalArticle

Thomas, Michael David ; Kocevar, Vasilisa Sazonov ; Zhang, Q. ; Yin, D. D. ; Price, David Brendan. / Asthma Related Healthcare Resource Use amongst asthmatic children with and without concommitant allergic rhinitis. In: Pediatrics. 2005 ; Vol. 115. pp. 129-131.
@article{a333ec0d2cb942fbaa26fde9674e2d27,
title = "Asthma Related Healthcare Resource Use amongst asthmatic children with and without concommitant allergic rhinitis",
abstract = "Objective. To determine the incremental effect of allergic rhinitis on health care resource use in children with asthma.Design. Population-based historical cohort study.Setting. Data in a general practice database in the United Kingdom during 1998 to 2001.Patients. Children 6 to 15 years old with asthma and with greater than or equal to1 asthma-related visits to a general practitioner (GP) during a 12-month follow-up period.Main Outcome Measures. Asthma-related hospitalizations, GP visits, and prescription drug costs during the 12-month follow-up period for patients with and without comorbid allergic rhinitis.Results. Of 9522 children with asthma, 1879 (19.7{\%}) had allergic rhinitis recorded in the GP medical records. Compared with children with asthma alone, children with comorbid allergic rhinitis experienced more GP visits (4.4 vs 3.4) and more of them were hospitalized for asthma (1.4{\%} vs 0.5{\%}) during the 12-month follow-up period. In multivariable regression analyses, comorbid allergic rhinitis was an independent predictor of hospitalization for asthma (odds ratio: 2.34; 95{\%} confidence interval [CI]: 1.41-3.91) and was associated with increases in the number of asthma-related GP visits (mean increase: 0.53; 95{\%} CI: 0.52-0.54) and asthma drug costs (mean increase pound: 6.7; 95{\%} CI: 6.5-7.0). The association between allergic rhinitis and higher costs of prescriptions for asthma drugs was independent of asthma severity, measured indirectly by the intensity of use of asthma drugs.Conclusions. Children with comorbid allergic rhinitis incurred greater prescription drug costs and experienced more GP visits and hospitalizations for asthma than did children with asthma alone. A unified treatment strategy for asthma and allergic rhinitis, as recommended by the Allergic Rhinitis and Its Impact on Asthma initiative, might reduce the costs of treating these conditions.",
keywords = "asthma, allergic rhinitis, children, medical resource use, BRONCHIAL RESPONSIVENESSbronchial responsiveness, United-States, cost, symptoms, rhinoconjunctivitis, inflammation, childhood, prevalence, increase",
author = "Thomas, {Michael David} and Kocevar, {Vasilisa Sazonov} and Q. Zhang and Yin, {D. D.} and Price, {David Brendan}",
year = "2005",
month = "1",
day = "1",
doi = "10.1542/peds.2004-0067",
language = "English",
volume = "115",
pages = "129--131",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",

}

TY - JOUR

T1 - Asthma Related Healthcare Resource Use amongst asthmatic children with and without concommitant allergic rhinitis

AU - Thomas, Michael David

AU - Kocevar, Vasilisa Sazonov

AU - Zhang, Q.

AU - Yin, D. D.

AU - Price, David Brendan

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Objective. To determine the incremental effect of allergic rhinitis on health care resource use in children with asthma.Design. Population-based historical cohort study.Setting. Data in a general practice database in the United Kingdom during 1998 to 2001.Patients. Children 6 to 15 years old with asthma and with greater than or equal to1 asthma-related visits to a general practitioner (GP) during a 12-month follow-up period.Main Outcome Measures. Asthma-related hospitalizations, GP visits, and prescription drug costs during the 12-month follow-up period for patients with and without comorbid allergic rhinitis.Results. Of 9522 children with asthma, 1879 (19.7%) had allergic rhinitis recorded in the GP medical records. Compared with children with asthma alone, children with comorbid allergic rhinitis experienced more GP visits (4.4 vs 3.4) and more of them were hospitalized for asthma (1.4% vs 0.5%) during the 12-month follow-up period. In multivariable regression analyses, comorbid allergic rhinitis was an independent predictor of hospitalization for asthma (odds ratio: 2.34; 95% confidence interval [CI]: 1.41-3.91) and was associated with increases in the number of asthma-related GP visits (mean increase: 0.53; 95% CI: 0.52-0.54) and asthma drug costs (mean increase pound: 6.7; 95% CI: 6.5-7.0). The association between allergic rhinitis and higher costs of prescriptions for asthma drugs was independent of asthma severity, measured indirectly by the intensity of use of asthma drugs.Conclusions. Children with comorbid allergic rhinitis incurred greater prescription drug costs and experienced more GP visits and hospitalizations for asthma than did children with asthma alone. A unified treatment strategy for asthma and allergic rhinitis, as recommended by the Allergic Rhinitis and Its Impact on Asthma initiative, might reduce the costs of treating these conditions.

AB - Objective. To determine the incremental effect of allergic rhinitis on health care resource use in children with asthma.Design. Population-based historical cohort study.Setting. Data in a general practice database in the United Kingdom during 1998 to 2001.Patients. Children 6 to 15 years old with asthma and with greater than or equal to1 asthma-related visits to a general practitioner (GP) during a 12-month follow-up period.Main Outcome Measures. Asthma-related hospitalizations, GP visits, and prescription drug costs during the 12-month follow-up period for patients with and without comorbid allergic rhinitis.Results. Of 9522 children with asthma, 1879 (19.7%) had allergic rhinitis recorded in the GP medical records. Compared with children with asthma alone, children with comorbid allergic rhinitis experienced more GP visits (4.4 vs 3.4) and more of them were hospitalized for asthma (1.4% vs 0.5%) during the 12-month follow-up period. In multivariable regression analyses, comorbid allergic rhinitis was an independent predictor of hospitalization for asthma (odds ratio: 2.34; 95% confidence interval [CI]: 1.41-3.91) and was associated with increases in the number of asthma-related GP visits (mean increase: 0.53; 95% CI: 0.52-0.54) and asthma drug costs (mean increase pound: 6.7; 95% CI: 6.5-7.0). The association between allergic rhinitis and higher costs of prescriptions for asthma drugs was independent of asthma severity, measured indirectly by the intensity of use of asthma drugs.Conclusions. Children with comorbid allergic rhinitis incurred greater prescription drug costs and experienced more GP visits and hospitalizations for asthma than did children with asthma alone. A unified treatment strategy for asthma and allergic rhinitis, as recommended by the Allergic Rhinitis and Its Impact on Asthma initiative, might reduce the costs of treating these conditions.

KW - asthma

KW - allergic rhinitis

KW - children

KW - medical resource use

KW - BRONCHIAL RESPONSIVENESSbronchial responsiveness

KW - United-States

KW - cost

KW - symptoms

KW - rhinoconjunctivitis

KW - inflammation

KW - childhood

KW - prevalence

KW - increase

U2 - 10.1542/peds.2004-0067

DO - 10.1542/peds.2004-0067

M3 - Article

VL - 115

SP - 129

EP - 131

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

ER -